Differential Gene Expression Pattern in Osteoclast Precursor Cells of Indian Postmenopausal Women with and Without Osteoporosis: A Microarray Based Study
Received Date: Oct 27, 2017 / Accepted Date: Nov 29, 2017 / Published Date: Dec 07, 2017
Background: Osteoporosis is a multifactorial disease with strong genetic and epigenetic component. In spite of enormous candidate gene association studies, the etiology and molecular mechanism of disease is not fully known. For identification of new markers of osteoporosis which could be vital in diagnosis and prognosis of disease, genome-wide microarray expression approach was employed.
Methods: Osteoclast precursor cells were sorted from circulating monocytes of osteoporotic and nonosteoporotic post menopausal females with similar life-style and year after menopause. Following microarray experimentation, gene enrichment analysis was performed on significant DEGs using Database for Annotation, Visualization and Integrated Discovery (DAVID) tool. Top 10 novel genes were further used for construction of protein-protein interaction network using Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database. To validate microarray gene expression pattern, Real time-PCR was performed.
Results: A total of 269 genes were found to be differentially expressed between disease and normal groups, of which 138 were observed to be up regulated and 131 down regulated. Furthermore, novel LHX1 gene was observed to be up regulated and its interaction with BMP4 protein was observed. Three known genes for osteoclastogenesis (viz., CX3CL1, ACP5 and CSF1) were found to be up- regulated. Similar pattern of gene expression have been obtained using RT-PCR.
Conclusion: Significant enrichment of PI3K-Akt and TGF-ß signaling pathways involving DEGs was found in postmenopausal Asian Indian women. Moreover, up regulated LHX1 gene was discovered as novel gene which may have a role in pathogenesis of osteoporosis and can be used for diagnosis and prognosis along with known osteoporotic markers.
Keywords: Osteoporosis; Monocytes; Osteoclast precursors; Microarray; Differential gene expression; LHX1 gene
Osteoclasts play a pivotal role in the bone resorption. Generally, the formation and resorption of the bone is tightly regulated by nutrition and intrinsic factors. However, when the resorption of the bone prevails over its formation, it leads to a skeletal disorder, osteoporosis. Osteoclast precursors are hematopoietic in origin and differentiate into osteoclasts to resorb bone . Osteoclasts are derived from macrophage colony-stimulating factor (M-CSF)-dependent blood precursors, including monocytes present in the peripheral blood mononuclear cell (PBMC) population. Osteoclast precursors circulate in the blood stream to find the correct site (bone surface) for osteoclastogenesis . If the bone surface is not available, differentiation of these precursors into osteoclasts may become insensitive and regain osteoclastogenesis when bound to bone. So adhesion of osteoclast precursors to bone dictates their fate . However, the most likely candidate for the osteoclast precursor in PBMC population is the CD14 marker, which is strongly expressed on monocytes. CD14+ cells are putative osteoclast precursors in the peripheral blood [4,5]. Like osteoclasts, immune cells also originate from hematopoietic stem cells and a link between immune cells and bone cells has revealed that along with RANK/RANKL/OPG system, activated T cells may both positively and negatively regulate bone resorption . Apart from these, hormones, interleukins, growth factors, nutrition, physical activity and lifestyle play a major role in the development, differentiation and maturation of osteoblasts and osteoclast precursor cells, suggesting that bone resorption is being influenced by both local and systemic factors . Thus, osteoporosis is a multifactorial disease in which genetic and epigenetic factors along with lifestyle play an important role .
For primary osteoporosis along with these factors, menopause status is the most vulnerable factor in women. Deficiency of estrogen with simultaneous increase in the FSH level accelerates bone loss inducing osteoporosis . Estrogen depletion recruits large number of osteoclast precursors to activate osteoclastogenesis [10,11]. Reduced enstrogen inhibits apopotosis of osteroclasts and facilitates the formation of osteoclasts by inducing osteoclast precursor sensitivity to receptor activator of nuclear factor kappa-B ligand (RANKL) induced osteoclastogenesis. Osteoclast precursors up regulate c-Jun activating kinase (JNK) resulting into increased bone resorption [12,13].
Although association studies have shown the involvement of genetic factors along with several candidate genes either singly or in group, the etiology of osteoporosis is not clearly understood.
To address this complex question researchers have also screened differential gene expressions of bone cells using high throughput microarray [14,15]. In most of these studies either the effect of estrogens, corticosteroids oxidative stress or some drugs on osteoblasts have been analyzed [16,17]. Only a handful of studies have focused on the gene expression pattern of osteoblasts obtained from bone marrow or bone biopsies or cell lines [16-18]. Further, some studies have also examined the gene expression profile of premenopausal women and primary osteoporosis [17,19]. Liu et al. (2005) studied the genome wide differential gene expression on circulating monocytes from osteoporotic and non-osteoporotic postmenopausal Caucasian females. However, they did not take into account the years lapsed after menopause, life style, diet and medication of the participating women, which influences the pattern of gene expression to a great extent . Moreover, their study included Caucasian and Asian Chinese populations. We know that factors such as duration of exposure to sun, diet, lifestyle etc. of Indians is completely different from Caucasian or Chinese populations. Very few reports are available on the status of osteoporosis in Indian women. Moreover, these studies are based on survey and questionnaire about lifestyle, sun exposure, nutrient intake etc. and their impact on Bone Mineral Density (BMD). These studies have shown that, vitamin D deficiency is a major factor for reduced BMD and high prevalence of osteoporosis in Indian population [21,22]. In Indian women from low income group with low nutrient diet, body weight, age and menopause are important determinants of BMD .
As per our knowledge, there are no studies on differential gene expression of osteoclast precursors and identification of osteoporosis specific genes in Asian Indian women. Hence, in the present study, we first tried to identify Differentially Expressed Genes (DEGs) in osteoclast precursor cells derived from Indian postmenopausal women having high bone mineral density (as a control) and primary osteoporosis. Further, we validated microarray data of five potential genes using reverse transcription polymerase chain reaction (RT-PCR). This is the first genome-wide expression study on ex situ human osteoclast precursor cells relating to etiology of osteoporosis in Indian postmenopausal women who have had almost similar life style and years lapsed after onset of menopause.
Material and Methods
The study was approved by the ethics committee of Savitribai Phule Pune University, Pune. Biological samples were collected after obtaining a written consent from female volunteers.
Bone mineral density (BMD) measurement
Bone mineral density (g/cm2) was measured at femoral neck and lumbar spine (L2-L4) using a dual X-ray absorptiometry (DEXA; 24). The osteoporotic and non-osteoporotic conditions were decided using world health organization (WHO) guidelines stating T score above -1 SD is non-osteoporotic and below -2.5 SD is osteoporotic condition. Based on this guideline for T score, participating subjects (n=72) were grouped into non-osteoporotic (n=36) and osteoporotic (n=36) to investigate DEGs pattern between them.
All participants were genetically unrelated postmenopausal females from Pune (18.5204°N, 73.8567°E), India. Subjects with secondary osteoporosis and chronic skeletal diseases (rheumatoid arthritis, osteogenesis etc.), metabolic disorders (diabetes and thyroidism), chronic conditions of internal organs (liver, kidneys etc.) and endocrine disorders undergoing hormonal therapies (hormone replacement, bisphosphonate, corticosteroid therapy) were excluded as these conditions possibly affect bone metabolism. Individuals fitting to inclusion criteria were recruited and information regarding family history of bone related diseases, medical history of hysterectomy, ovariectomy, menstrual history, dietary habits, physical activity, lifestyle (alcohol, smoking etc.) and calcium supplementation, number of children and duration of lactation was collected. Median body mass index (BMI; kg/m2) and years after menopause matched females (n=8) with osteoporosis (n=4) and non-osteoporosis (n=4) were selected for microarray analysis. All the subjects, (normal=32 and osteoporosis=32) in the age group of 45-60 years were selected for the gene expression validation study by RT-PCR.
Osteoclast precursor cell sorting
Whole blood (25 ml) from each selected subject was collected in EDTA vials. This was divided into two vials: one with 15ml for CD14+ cell sorting and second with 10 ml for total RNA isolation. PBMCs of were isolated from whole blood of both vials by fractionating on Hypaque 1077. Isolated PBMCs from 15 ml blood vial were resuspended in 1 ml of isolation buffer (Ca2+ and Mg2+ free PBS supplemented with 0.1% BSA and 2 mM EDTA, pH 7.4) and cell count was taken. An average of ~ 1.5 × 107 cells/ml were obtained and subjected to CD14+ sorting as CD14 is a putative osteoclast precursor in the peripheral blood [4,5]. CD14+ cells were sorted from circulating monocytes using Dynabeads® CD14 positive isolation kit (INVITROGEN, MA, USA) following the manufacturer’s protocol . As these Dynabeads are coated with primary monoclonal antibody exclusive for CD14 membrane antigen, it efficiently eliminates T cells, B cells, natural killer cells, CD16+ and granulocytes and gives ~95% pure CD14+ cells.
Total RNA was isolated from these CD14+ cells using Trizol reagent (LIFE TECHNOLOGIES, CA, USA) and was purified using RNeasy mini kit (QUIGENE, Hilden, Germany). Total cDNA was synthesized from 1μg total RNA using Verso cDNA synthesis kit (THERMO FISHER SCIENTIFIC, MA, USA). Reverse transcription reaction was set according to manufacturer’s protocol followed by RT-PCR for c- FMS and RANK genes which are markers for osteoclast precursors. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene was used as an internal control. Following thermal cycler program was used: 95°C for 10 min, 95°C for 30 s, 58°C for 1 min, 60°C for 35 s, 95°C for 15 s, 60°C for 1min and 95⁰C for 15 s with 40 cycles. SYBR green chemistry was used to assess the melt curves on Step one plus (APPLIED BIOSYSTEMS, CA, USA) thermal cycler. The composition of PCR was 50 ng cDNA in a total reaction volume of 10μl using 5 μl DyNAmo ColorFlash SYBR Green qPCR Kit (THERMO FISHER SCIENTIFIC, MA, USA) and 10 pM each of forward and reverse primers. Following primers were used for genes used as markers for osteoclast precursors- GAPDH- F: TGGGGAAGGTGAAGGTCGGA, R: GGGATCTCGCTGCTGGAAGA, c-FMS- F: CCTAGCACAGGAGGTGGTCGT, R: GGTGTTGTTGTGTTGGAGGA, RANK- F: CCTGAAGAAGAAGCCAGCAG, R: CGTAGACCACGATGATGTCG.
Gene Chip hybridization
After confirming presence of osteoclast precursor specific markers, total RNA from control (n=4) and osteoporotic (n=4) individuals was used for in-vitro transcription. Biotin labeling was carried out using CY3 dye of Agilent quick-Amp labeling kit and amplified using T7 promoter. The Quality of Biotinylated cRNA was assessed by Nanodrop and all the samples were found to be suitable for further hybridization. Integrity of RNA was checked by assessing the ratio of 18S and 28S ribosomal RNA intensity peaks (Agilent 2100 Expert Bioanalyzer; Table 1). Human Genechip® Agilent’s in-situ hybridization kit 5190-6420 was used which covers approximately 60K oligonucleotide probes. Experimental procedure for microarray hybridization and scanning was performed according to manufacturer’s protocol (AGILENT TECHNOLOGIES, CA, USA).
|Sample no. of participants||‘T’ score [SD]||RNA concentration [ng/ml]||Absorbance value [260/280]||RNA Integrity Number|
|Normal [n = 4]|
|Osteoporosis [n = 4]|
Table 1: Anthropometric and isolated RNA details of eight female subjects (age group 50 - 60 yrs) used for microarray study. Note: Sample no. of participant indicates 1-4 are normal or non osteoporotic individuals and 5-8 are osteoporotic individuals.
Statistical and software analysis
The data generated by microarray hybridization was intra-array normalized using Genespring GX (version: 13.0) software. For interarray normalization, median values of 4 normal and 4 osteoporosis females across all genes (spots / entity) were considered. From the median value of each entity of osteoporosis, the median value of normal was subtracted. This normalized data was used for log twofold change (FC) calculation. The relative gene expression achieved through RT-PCR was computed using following formula:
Relative gene expression = 2-ΔCt,
where ΔCt= [Ct (target gene)-Ct (GAPDH)]
Difference in the expression pattern of five genes between control and osteroporosis subjects was analyzed using One- way analysis of variance (ANOVA). Pearson’s chi-square test was carried out to assess the significant difference in expression of genes using RT-PCR among normal and disease groups. Microarray data was analysed using GeneSpring GX version: 13.0 software (AGILENT TECHNOLOGIES). Raw data files from Agilent- AMADID: 39494 platform were subjected to RAM (Robust Multichip Averaging) algorithm to normalize the data. The quantile normalization has been implemented with median of all samples taken for baseline transformation. Gene expression profiles of osteoporotic as well as control subjects were studied by generating a differentially expressed genes (DEGs) list. A paired t test was applied using asymptotic method on the normalized data assuming equal variances, incorporating Benjamini and Hochberg False Discovery Rate (FDR) multiple-testing correction set at a rate of 0.05
Screening of differential genes
Differentially expressed genes between osteoporotic and normal samples were identified using Genespring GX version: 13.0 software. False discovery rate of 0.05 was used as a cut off criterion. Differentially expressed genes of protein probes were also filtered out. This normalized and processed microarray data for DEGs of osteoclast precursors was then submitted to NCBI- Gene Expression Omnibus (GEO) repository. The NCBI-GEO accession number is: GSE100609.
Gene cluster analysis
Initial gene clustering of osteoporosis and control groups was carried out using Array Mining online tool (http://arraymining.net/). The gene expression data matrix was analyzed for hierarchical clustering which builds cluster of genes with similar pattern of expression.
GO enrichment analysis
Gene ontology is a common approach for functional studies of large scale genomic data. Gene enrichment analysis of DEGs was performed using web-based program - Database for Annotation, Visualization and Integrated Discovery (DAVID version: 6.8). After uploading the official symbols of DEGs onto the DAVID website (https://david.ncifcrf.gov/), the online functional annotation tool was applied to identify the pathways related to these genes for ‘Homo sapiens’ in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. Enrichment of pathways for DEGs on a KEGG pathway was considered statistically significant only if the Bonferroni-adjusted p<0.05. DAVID endows with a complete set of functional annotation tools to search high-throughput and integrated data-mining environment for the osteoporosis related and predicted genes.
Protein-protein interaction (PPI) network analysis
Protein-Protein interaction network of top ten DEGs was constructed using search tool for the retrieval of interacting genes/ proteins (STRING) database version: 10.0 (http://string-db.org/). It is an online biological database and web resource which provides known direct (physical) and indirect (functional) protein-protein interactions.
Transcription factor analysis
Prediction of transcription factors regulating these DEGs were analyzed using TFBS tool of DAVID program. Additionally, prediction of target genes in a biological system and their regulation by known transcription factors was analyzed using TFactS online tool (www.tfacts.org).
Real time RT-PCR analysis
Isolated PBMCs from 10 ml blood were used for total RNA isolation using Trizol following cDNA synthesis from 1μg total RNA using Verso cDNA synthesis kit (Thermo scientific). Apart from eight samples used for microarray hybridization reaction, others (normal = 32 and osteoporotic = 32) were used for quantitative real time PCR. Five DEGs viz, Colony Stimulating Factor 1(CSF1), Acid Phosphatase 5 (ACP5), Chemokine (C-X3-C motif) Ligand 1(CX3CL1) and LIM Homeobox 1 (LHX1) based on their role in the bone metabolism and statistical significance were selected and their microarray gene expression was validated by RT-PCR using GAPDH as an endogenous control. Quantitative RT PCR was performed on Applied Biosystems Step one plus machine in total of 10ul of reaction volume with 50ng cDNA using 5μl DyNAmo ColorFlash SYBR Green qPCR Kit (Thermo scientific) and 10pM each of forward and reverse primers. The primers were GAPDH- F: GGAGTCAACGGATTTGGT, R: GTGATGGGATTTCCATTG, CSF1- F: AAGTTTGCCTGGGTCCTCTC, R: CATACGGGCAGCTGGGTC, ACP5- F: CTTTCTACCGCCTGCACTTC, R: GTTTCTTGAGCCAGGACAGC, CX3CL1- F: CTCCTCTTCTGCCTGGGGGTG, R: AGGAGTTCACACGGGCACCA and LHX1- F: GGGGGCAACTACGACTTCTT, R: GATGACGGCACGAAGGGTAG. The conditions for PCR were – 95°C for 10 min, 95°C for 30 s, 58°C for 1 min, 60°C for 35 s, 95°C for 15 s, 60°C for 1 min and 95°C for 15 s with 40 cycles. All the reactions were run in triplicate along with negative control for each gene.
DEGs suggested by microarray analysis
Microarray data were processed and normalized to obtain DEGs among osteoporotic subjects. A total of 556 differentially expressed genes with threshold of p<0.05 were filtered. Following exclusion of protein probes, 269 DEGs were screened of which 138 were up regulated and 131 down regulated genes. The hierarchical clusters based on 15 DEGs ensured that the screened genes have significant differences between osteoporotic and normal subjects. Further, principal component analysis of the samples also gave similar results for two separate clusters (Figure 1).
Figure 1: 2D Clustering of osteoporotic and normal samples based on 15 differentially expressed genes characteristic of osteoclast precursors and involved in early osteoclast differentiation using ArrayMining - online microarray data mining program. Horizontal dendogram depicts osteoporosis and non-osteoporosis subjects forming two separate clusters represented in columns. Vertical dendogram shows selected genes clustering together based on their expression value.
Prediction of novel osteoporosis genes
Osteropotic genes were chosen based on two criteria i) potential functional relevance of DEGs to bone metabolism and ii) statistical significance. With the first criterion, four genes namely, CX3CL1, CSF1, ACP5 and SMAD2 were screened out for their significant involvement in osteogenesis. CSF1, ACP5 and CX3CL1 are known osteoclastogenesis genes and were up-regulated. Though SMAD2 was significantly down-regulated, further emphasize on SMAD 2 was not given as it’s an osteoblastogenesis specific marker. Based on the second crieterion top ten up-regulated and down-regulated genes were screened out as novel. First twenty DEGs with their corresponding fold change and p-value obtained by microarray are discussed in the supplementary Table 1.
Interaction of these genes in the bone metabolism was evaluated using STRING database, which indicated the association of LHX1 with bone metabolism. LHX1 gene was also involved in osteoblast development (GO:0002076), differentiation (GO:0001649) and its regulation (GO:0045667) with false discovery rates below 0.05. LHX1 protein also showed its interaction with BMP4, CSF1, ACP5 and SMAD2 which are known potential osteogenesis markers.
Protein protein Interaction analysis
Analysis of protein-protein interactions (PPIs) was performed on DEGs to construct network of their interaction using STRING software. The prediction of critical genes for osteoporosis was done and combined interactions were expressed as histogram. The hub nodes of interaction for osteoporosis (namely SMAD2, BMP4, RLIM and LHX1) were identified (Figure 2). Node LHX1 (p=0.0002) was observed to be interacting with maximum number of genes involved in disease (SMAD2, BMP4, FOXA2, SFRP5, LDB2, LDB1, SHH and RLIM) with PPI enrichment score 0.000312 implicating LHX1 as the key gene associated with osteoporosis among Asian Indians. Thus, LHX1 was considered as fourth gene along with CSF1, CX3CL1 and ACP5 as probable markers in the predisposition of postmenopausal Asian Indian women for osteoporosis and for validation study by RTPCR.
Since the expressions of majority of 269 DEGs (listed in supplementary Table 1) have not been validated with real time PCR, significance (i.e. the p-value) of their differential expression is interpreted with caution.
Functional analysis of DEGs in osteoporosis
Gene ontology analysis was performed to know biological processes associated with DEGs using DAVID. In the functional cluster analysis, eight clusters were formed of which three clusters with enrichment score >0.05 were selected. We found that DEGs were mostly involved in the TGF-beta receptor signalling pathway (enrichment score 1.04), SMAD protein signal transduction (enrichment score 0.71), cell adhesion (enrichment score 0.58), etc. The genes which were significantly involved in these processes were SMAD2, SKI (TGF-beta receptor signalling pathway), INHBA (SMAD protein signal transduction) EMP2, CX3CL1, NCAN (Cell adhesion), etc.
The pathways for osteoporosis were analyzed using KEGG Mapper v2.8, a web based database. Our DEGs were associated with pathways like PI3k-Akt signaling pathway (CX3CL1, ACVR1, CSF1, IL17A, etc.), RAP1 & RAS signaling pathway (CSF1, FGF11, FGF8), TGF-beta signaling pathway (SMAD2, SMAD5, ACVR1, INHBA), which are known to participate in osteogenesis. A list of DEGs involved in the pathways is summarized in Table 2.
|Annotation [pathway/process]||Overlap size||list of genes|
|hsa01100:Metabolic pathways||14||AUH, SEPHS2, PYCRL, POLR1E, POLR1A, LIPT1, HYAL1, GALT, CES1, ASS1, UGCG, UGDH, NAT1, CDS2,|
|hsa04080:Neuroactive ligand-receptor interaction||10||F2RL1, ADRB1, ADRB3, CHRM4, GRIN2C, GRIN3B, PTAFR, PRLR, SSTR4, S1PR4,|
|hsa04060:Cytokine-cytokine receptor interaction||8||CX3CL1, ACVR1, CSF1, IL17A, KDR, PRLR|
|hsa04151 PI3K-Akt signalling pathway||8||COMP,CSF1,FGF11,FGF8,ITGB8,KDR,PRLR,TNC|
|hsa05200:Pathways in cancer||7||RAD51, SMAD2, FGF11, FGF8, MMP1, RET|
|hsa04144:Endocytosis||7||SMAD2, ADRB1, ADRB3, CHMP1B, KDR, PARD6A, RET, SMAD2|
|hsa04015 Rap1 signalling pathway||6||CSF1, FGF11, FGF8,KDR, PARD6A, SIPA1|
|hsa04810:Regulation of actin cytoskeleton||5||BAIAP2, CHRM4, FGF11, FGF8, ITGB8|
|hsa04350:TGF-beta signalling pathway||4||SMAD2, SMAD5, ACVR1, INHBA,|
|hsa04014 Ras signalling pathway||4||CSF1, FGF11, FGF8, KDR|
|hsa04510 Focal adhesion||4||COMP, ITGB8, KDR, TNC|
|hsa04550 Signalling pathways regulating pluripotency of stem cells||4||ACVR1,INHBA, SMAD2, SMAD5|
|hsa05323 Rheumatoid arthritis||4||ACP5, CSF1, IL17A, MMP1|
Table 2: list of genes involved in the GO enrichment pathway analysis using KEGG database.
Validation of selected DEGs with RT-PCR
Differential expression of CX3CL1, CSF1, ACP5 and LHX1 was validated using qRT PCR. For this purpose, RNA isolated from CD14+ cells as well as from PBMCs was used. The pattern of relative gene expression was (complementary) with the microarray data indicating significant up regulation of LHX1 gene. A significant increase in the CSF1 gene expression could be because of fewer years (4 years) after menopause onset (Figure 3).
Transcription factor (TF) binding site analysis
Binding of TFs and the regulation of DEGs were analyzed by TFactS database. Altogether we found 60 different TFs of which TFs regulating only CX3CL1, CSF1, ACP5 and LHX1 were analyzed. LHX1 did not interact with any TFs. Moreover, TFs such as c-JUN, NFKB1, MITF, CREB1 etc. were involved in the pathways leading to the differentiation of osteoclast precursors to osteoclasts.
Osteoclast precursors are progenitors of osteoclasts. Hence, determining the expression pattern of genes in osteoclast precursors may help in understanding not only the predisposition to the disease but also its prognosis. In the present study, we have analysed global gene expression pattern of osteoclast precursors for osteoporosis using microarray system. Four genes CX3CL1, CSF1, ACP5 and LHX1 were found to be differentially expressed significantly in our study samples with their involvement in bone metabolism. Up-regulation of CX3CL1 was observed in the osteoclast precursors from peripheral blood. A possible reason could be its functional involvement in the migration of osteoclast precursors from peripheral blood to the bone surface [26,27]. It is known that CSF1 through its receptor c-fms induces proliferation and survival of osteoclasts, whereas ACP5 is a wellknown osteoclast specific marker .
Our results of DEGs, TFs, PPIs, gene ontology and previous findings (29-34) suggest that hematopoietic cells in presence of transcription factor PU.1 form Myeloid/ Monocyte lineage cells like osteoclast precursors [29,30]. CSF1 on binding with its receptor c-fms on osteoclast precursor provides signals for osteoclast proliferation which are manifested through RAS and PI3K dependent mechanisms [31,32]. RAS a small G-protein promotes activation of RAS/PI3K and Raf/MEK/ERK pathway . RAS/PI3K signaling pathway triggers downstream cascade reactions leading to osteoclast survival.
In the RAS signaling pathway, Angiotensin II type 1 receptor (AT1) induces osteoclast differentiation by decreasing osteocalcin activity and induces high bone turnover leading to osteoporosis . On the other hand, PI3K activity is either regulated by RAS activation or mediated independently. On receiving the signals from CSF1, cytoplasmic tyrosine residues of c-FMA get phosphorylated along with c-src recruitment. This process induces PI3K to activate AKT and ERK signaling pathways resulting into the proliferation and survival of osteoclast precursors [35-38]. Further, PI3K-RAP1 signaling pathway actively promotes osteoclast cell adhesion through extracellular ADP factor and mediates focal adhesion turnover assembly . Our results based on pathway analysis of DEGs were in accordance with these earlier findings.
Similarly, the expression of RANK in early osteoclast precursors is essential for their differentiation to mature osteoclasts . Binding of RANK-RANKL recruits TRAF6, which activates TGF-beta –activated Kinase 1 (TAK1) and downstream signaling factors such as P38 mitogen-activated protein kinase (P38 MAPK), NF-κ-beta (p50/52) and JNK1 inducing c-FOS/c-JUN. NF-κ-beta in turn activates NFATC-1, one of the vital transcription factors along with MITF and CREB1 that are involved in the differentiation of osteoclast precursors to mature osteoclasts . At this state osteoclast specific genes such as ACP5, CTSK, etc. exhibit increased expression. Our microarray data also show up- regulation of these TFs and genes. However, one of the reasons for low RANK expression in our microarray data could be the circulating osteoclast precursors. It has been reported that osteoclast precursors generated from circulating monocytes express low level of RANK (RANKlow and c-FMShigh) than those derived from bone marrow stromal cells . Our analysis for gene ontology also supports these findings. In the present study we observed significant enrichment of TGF-beta signaling pathway process, transcription factors such as NF-κ-beta, c-JUN, CREB1, MITF, etc. and significantly high expression of ACP5 gene.
Earlier study by Trost, et.al suggested role of oxidative stress on pathogenesis of osteoporosis. Upregulated AOX1, TXNRD1, GSR and MT1G genes in osteoblast cells are important mediators of the stress response . Our results on osteoclast precursors did not show differential expression of these genes suggesting increased tendency towards osteoclastogenesis. Liu, et.al in Caucasian population found three genes viz., CCR3, HDC and GCR to be significantly upregulated. These genes play an important role in monocyte recruitment into bone and their differentiation into osteoclasts . In our study we did not find these markers to be upregulated significantly. This difference could be because of difference in the ethnicity and selection of monocyte subpopulation containing CD16+ cells by Liu, et.al. Whereas, our study specifically involves CD14+ cells which are putative osteoclast precursors in the peripheral blood.
Apart from these bone specific genes LIM Homeobox (LHX1) gene was also up regulated in the osteoporosis group in our study. Previous studies have shown involvement of LHX1 gene in the intramembranous skull formation during development [43,44]. There are virtually no reports on the direct association of LHX1 with osteoporosis. However, LHX 2 is strongly expressed in osteoclast precursors and reported to regulate osteoclastogenesis by modulating RANKL signals. LHX 2 knockout mice exhibited osteoporotic bone phenotype with increased osteoclast formation . Moreover, LHX1 is regulated by transcription factors such as ATF2, c-FOS/c-JUN, which were not only up regulated in our study but also top the list of ten transcription factors, suggesting the involvement of LHX1 in osteoporosis. Hence, we propose it as a novel gene for the predisposition for osteoporosis in the postmenopausal Asian Indians.
Our microarray analysis for primary osteoporosis in Asian Indians reveals a complex interaction of cytokines, genetic markers, their regulatory elements and signaling pathways, which may play a central role in elevated osteoclastogenesis . Cytokine CSF1 along with genetic markers such as ACP5, CX3CL1 endorses osteoclastogenesis through PI3k-Akt and TGF-β signaling pathways. LHX1 appears to be a novel gene implicated in osteoporosis suggesting its crucial role in pathogenesis of osteoporosis especially in the postmenopausal Indian females. This may aid in molecular pathogenesis and developing novel prospective for prognosis against primary osteoporosis for Asian Indian population.
We are grateful to the volunteers and osteoporosis patients for their whole-hearted participation in this ongoing study.
MMR received fellowship from University grant commission, and STM from Council of Scientific and Industrial research [CSIR], Govt. of India. The authors thank Department of Biotechnology [DBTBT/ PR/4634/MED/12/536/2012], University Grants Commission [MRP-MAJOR-ZOOL-2013-28006], Department of Science and Technology – Promotion of University Research and Scientific Excellence [DST-PURSE; GOI-A-670] and Departmental research and Development program [DRDP] for financial support.
RA and MW designed the study plan. MR has carried out the clinical and molecular work along with SM. PG, RA and MR has performed the microarray data analysis. MW has provided his expertise in editing the manuscript along with RA. All authors read and approved the final draft of manuscript.
Present study was approved by ethics committee of Savitribai Phule Pune University. Biological samples were collected after obtaining written informed consent from female volunteers.
Conflict of Interest
Mehrunnisa M. Raje, Suhas T. Mhaske, Payel Ghosh, Mohan R. Wani and Richa Ashma declares that they have no conflict of interest
- Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4: 638-649.
- Muto A, Mizoguchi T, Udagawa N, Ito S, Kawahara I, et al. (2011) Lineage‐committed osteoclast precursors circulate in blood and settle down into bone. J Bone Miner Res 26: 2978-2990.
- De Vries TJ, Schoenmaker T, Aerts D, Grevers LC, Souza PP, et al. (2015) M‐CSF Priming of Osteoclast Precursors Can Cause Osteoclastogenesis‐Insensitivity, Which Can be Prevented and Overcome on Bone.J Cell Physiol 230: 210-225.
- Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, et al. (2000)Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor κB ligand (RANKL). Clin Sci (Lond) 99: 133-140.
- Sprangers S, Schoenmaker T, Cao Y, Everts V, De Vries TJ (2016) Different Blood‐Borne Human Osteoclast Precursors Respond in Distinct Ways to IL‐17A. J Cell Physiol 231: 1249-1260.
- Giorgio Mori, Patrizia D'Amelio, Roberta Faccio, Giacomina Brunetti (2013) The Interplay between the Bone and the Immune System. Clinical and Developmental Immunology 2013: 16.
- R. Bartl, C. Bartl (2016) Bone Disorders. Switzerland.
- Marini F, Cianferotti L, Brandi ML (2016) Epigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices? Int J Mol Sci 17: 1329.
- Wang J, Zhang W, Yu C, Zhang X, Zhang H, et al. (2015) Follicle-stimulating hormone increases the risk of postmenopausal osteoporosis by stimulating osteoclast differentiation. PloS one 10: e0134986.
- Lerner UH (2016) Bone remodeling in post-menopausal osteoporosis J Dent Res 85: 584-95.
- Oursler MJ (2003) Direct and indirect effects of estrogen on osteoclasts. J Musculoskel Neuron Interact 3: 363-366.
- Novack DV (2007) Estrogen and bone: osteoclasts take center stage. Cell Metab 6: 254-256.
- Faienz MF, Ventura A, Marzano F, Cavallo L (2013) Postmenopausal osteoporosis: the role of immune system cells. Clin Dev Immunol 2013: 575936
- Balla B, Kósa JP, Kiss J, Borsy A, Podani J, et al. (2008) Different gene expression patterns in the bone tissue of aging postmenopausal osteoporotic and non-osteoporotic women. Calcif Tissue Int 82: 12-26.
- Trošt Z, Trebše R, Preželj J, Komadina R, Logar DB, et al. (2010) A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts. Bone, 46: 72-80.
- Leclerc N, Luppen CA, Ho VV, Nagpal S, Hacia JG, et al. (2004). Gene expression profiling of glucocorticoid-inhibited osteoblasts. J Mol Endocrinol 33: 175-193
- Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B, Inoue S (2007) Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells. J Mol Endocrinol 39: 239-247.
- Hopwood B, Tsykin A, Findlay DM, Fazzalari NL (2009) Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone 44: 87-101.
- Chen XD, Xiao P, Lei SF, Liu YZ, Guo YF, et al. (2010) Gene expression profiling in monocytes and SNP association suggest the importance of the STAT1 gene for osteoporosis in both Chinese and Caucasians. J Bone Miner Res 25: 339-355.
- Liu YZ, Dvornyk V, Lu Y, Shen H, Lappe JM, et al. (2005) A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem 280: 29011-29016.
- Malhotra N, Mithal A (2008) Osteoporosis in Indians. Indian J Med Res 127:263-268.
- Raje M, Botre C, Ashma R (2013) Genetic epidemiology of osteoporosis across four microsatellite markers near the VDR gene. Int J Mol Epidemiol Genet 4: 101-108.
- Shatrugna V, Kulkarni B, Kumar PA, Ran KU, Balakrishna N (2005) Bone status of Indian women from a low-income group and its relationship to the nutritional status. Osteoporos Int 16: 1827-1835.
- World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Pp: 843-845.
- Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD, et al. (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 282: 5691-5703.
- Matsuura T, Ichinose S, Akiyama M, Kasahara Y, Tachikawa N, et al. (2017) Involvement of CX3CL1 in the Migration of Osteoclast Precursors across Osteoblast Layer Stimulated by Interleukin‐1ß. J. Cell. Physiol. 232: 1739-1745.
- Ishii T, Kikuta J, Kubo A, Ishii M (2010) Control of osteoclast precursor migration: a novel point of control for osteoclastogenesis and bone homeostasis. IBMS BoneKEy 7: 279-286.
- Na Kyung Lee (2010) Molecular Understanding of Osteoclast Differentiation and Physiology. Endocrinol Metab, 25: 264-269.
- Sharma SM, Bronisz A, Hu R, Patel K, Mansk KC, et al. (2007) MITF and PU. 1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem. 282: 15921-15929.
- Lu SY, Li M, Lin YL (2010) Mitf induction by RANKL is critical for osteoclastogenesis. Molecular biology of the cell 21: 1763-1771.
- Ross FP (2006) M‐CSF, c‐Fms, and Signaling in Osteoclasts and their Precursors. Annals of the New York Academy of Sciences, 1068: 110-116.
- Curry JM, Eubank TD, Roberts RD, Wang Y, Pore N, et al. (2008) M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PloS one 3: e3405.
- Gebru Y, Diao TY, Pan H, Mukwaya E, Zhang Y (2013) Potential of RAS inhibition to improve metabolic bone disorders. BioMed research international 2013: 1-6.
- Kelley TW, Graham MM, Doseff AI, Pomerantz RW, Lau SM (1999) Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J. Cell. Biochem 274: 26393-26398.
- Varticovski L, Druker B, Morrison D, Cantley L, Roberts T (1989) The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase. Nature 342: 699-702.
- Bradley EW, Ruan MM, Vrable A, Oursler MJ (2008) Pathway crosstalk between Ras/Raf and PI3K in promotion of M‐CSF‐induced MEK/ERK‐mediated osteoclast survival. J. Cell. Biochem 104: 1439-1451.
- Kim JH, Kim N (2016) Signaling pathways in osteoclast differentiation. Chonnam Med J 52: 12-17.
- Gingery A, Bradley E, Shaw A, mOursler MJ (2003) Phosphatidylinositol 3‐kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival. J. Cell. Biochem 89: 165-179.
- Fuss B (2013) Signaling pathways mediating adhesion and spreading through extracellular ADP and the P2Y12 receptor. Purinergic signalling 9: 131-133.
- Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL–RANK signaling in osteoclastogenesis and bone disease. Trends in molecular medicine, 12: 17-25.
- Raggatt LJ, Partridge NC (2010) Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 285: 25103-25108.
- Zoran T, Rihard T, Janez P, Radko K, Darja BL, et al. (2010) A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts. Bone 46: 72– 80.
- Haberland M, Mokalled MH, Montgomery RL, Olson EN (2009) Epigenetic control of skull morphogenesis by histone deacetylase 8. Genes & development 23: 1625-1630.
- Shawlot W, Behringer RR (1995) Requirement for Lim1 in head-organizer function. Nature 374: 425.
- Kim JH, Youn BU, Kim K, Moon JB, Lee J, et al. (2014) Lhx 2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts. Cell Death and Differentiation21: 1613-1621.
Citation: Raje MM, Mhaske ST, Ghosh P, Wani RM, Ashma R (2017) Differential Gene Expression Pattern in Osteoclast Precursor Cells of Indian Postmenopausal Women with and Without Osteoporosis: A Microarray Based Study. J Bone Res 5:185. Doi: 10.4172/2572-4916.1000185
Copyright: © 2017 Raje MM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
International Conference on Emergency & Acute Care Medicine August 22-23, 2018 Tokyo, Japan
August 22-23, 2018 Tokyo, Japan
14th International Conference on Clinical Gastroenterology and Hepatology August 29-30, 2018 Toronto, Ontario, Canada
August 29-30, 2018 Toronto, Canada
World Conference on Neurology and Neuromuscular Disorders September 13-14, 2018 Frankfurt, Germany
September 13-14, 2018 Frankfurt, Germany
9th International Conference on Clinical & Medical Case Reports September 17-18, 2018 | Amsterdam, Netherlands
September 17-18, 2018 Amsterdam, Netherlands
World Congress on Fetal and Maternal Medicine October 15-17, 2018 Osaka, Japan
October 15-17, 2018 Osaka, Japan
Complementary & Alternative Medicine October 17-18, 2018 Las Vegas | Nevada | USA
October 17-18, 2018 Las Vegas, USA
11th International Conference on Clinical and Medical Case Reports October 22-23, 2018 Turkey
October 22-23, 2018 Istanbul, Turkey
- Total views: 593
- [From(publication date): 0-2017 - Jun 25, 2018]
- Breakdown by view type
- HTML page views: 558
- PDF downloads: 35